Published in J Pharmacol Exp Ther on August 01, 1954
Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man. J Clin Invest (1969) 2.47
The distribution and excretion of phenobarbital. J Clin Invest (1957) 1.84
The time course of barbiturate action in man investigated by measurement of smooth tracking eye movement. Br J Pharmacol Chemother (1968) 1.82
A comparison of the effects of six barbiturates and a placebo on insomnia and motility in psychiatric patients. Br J Pharmacol Chemother (1963) 1.34
Therapeutic drug monitoring--antiepileptic drugs. Br J Clin Pharmacol (1998) 0.86
Dose-related effects of phenobarbitone on human sleep-waking patterns. Br J Clin Pharmacol (1981) 0.76
PERSISTENCE OF BARBITURATES. Br Med J (1963) 0.75
Evaluation of methyprylon in chronic insomniac patients with various physical disorders. J Natl Med Assoc (1962) 0.75
Biliary excretion of barbiturates. Br J Pharmacol (1971) 0.75
A simple ultraviolet spectrophotometric method for the determination of protein. J Lab Clin Med (1956) 9.66
Calculation of intracellular pH from the distribution of 5,5-dimethyl-2,4-oxazolidinedione (DMO); application to skeletal muscle of the dog. J Clin Invest (1959) 5.78
Reduction of carbon tetrachloride in vivo and reduction of carbon tetrachloride and chloroform in vitro by tissues and tissue constituents. J Pharmacol Exp Ther (1961) 2.53
The distribution and excretion of phenobarbital. J Clin Invest (1957) 1.84
Metabolic demethylation of 3-methyl-5-ethyl-5-phenyl hydantoin (Mesantoin). J Pharmacol Exp Ther (1952) 1.48
Intracellular pH of isolated perfused turtle heart. Am J Physiol (1960) 1.47
Quantitative studies of the demethylation of trimethadione (tridione). J Pharmacol Exp Ther (1953) 1.27
N-methylated derivatives of barbituric acid, hydantoin and oxazolidinedione used in the treatment of epilepsy. Neurology (1958) 1.16
Renal excretion of 5,5-dimethyl-2-4-oxazolidinedione (product of demethylation of trimethadione. Proc Soc Exp Biol Med (1957) 1.14
Theories of general anesthesia. J Pharmacol Exp Ther (1950) 1.12
Metabolic demethylation of 3, 5, 5-trimethyl-2, 4-oxazolidinedione (trimethadione, tridione). Proc Soc Exp Biol Med (1952) 1.10
The metabolic conversion of 5, 5-diphenyl hydantoin to 5-(p-hydroxyphenyl)-5-phenyl hydantoin. J Pharmacol Exp Ther (1957) 1.07
The rate of penetration of barbituric acid derivatives into the brain. J Pharmacol Exp Ther (1950) 1.05
The metabolic hydroxylation of phenobarbital. J Pharmacol Exp Ther (1956) 0.92
Metabolic transformations of trichlorethylene. J Pharmacol Exp Ther (1949) 0.91
Metabolic conversion of primidone (mysoline) to phenobarbital. Proc Soc Exp Biol Med (1956) 0.90
Lysis of dog erythrocytes in mildly alkaline isotonic media. Am J Physiol (1956) 0.89
Introduction; termination of drug action by elimination of unchanged drug. Fed Proc (1958) 0.87
The role of the liver in the demethylation of N-methyl derivatives of hydantoin and of 2,4-oxazolidinedione. J Pharmacol Exp Ther (1954) 0.85
The effects of N-methylation in 5,5-disubstituted derivatives of barbituric acid, hydantoin, and 2-4-oxazolidinedione. J Am Pharm Assoc Am Pharm Assoc (1955) 0.83
THE METABOLIC FATE OF 5-ALLYL-5-(1-METHYLBUTYL)BARBITURIC ACID (SECOBARBITAL). J Pharmacol Exp Ther (1965) 0.83
Quantitative studies of the metabolic fate of mephobarbital (N-methyl phenobarbital). J Pharmacol Exp Ther (1952) 0.82
The metabolic fate of 5-(1-cyclohexen-1-yl)-1, 5-dimethyl barbituric acid (hexobarbital, evipal) and of 5-(1-cyclohexen-1-yl)-5-methyl barbituric acid ("nor-evipal"). J Pharmacol Exp Ther (1953) 0.81
Demethylation of N-methyl derivatives of barbituric acid, hydantoin, and 2,4-oxazolidinedione by rat liver microsomes. Life Sci (1963) 0.80
The metabolic fate of chloral hydrate. J Pharmacol Exp Ther (1948) 0.78
A SIMPLE, RAPID METHOD FOR PAPER CHROMATOGRAPHY OF BARBITURATES. Clin Chem (1965) 0.78
A STUDY OF THE PRODUCT OF DEMETHYLATION OF TRIMETHADIONE IN THE CONTROL OF PETIT MAL EPILEPSY. Neurology (1965) 0.78
Quantitative studies of the demethylation of N-methyl barbital (metharbital, gemonil). J Pharmacol Exp Ther (1953) 0.78
The role of the liver in the metabolic disposition of mephoparbital. J Pharmacol Exp Ther (1952) 0.77
Reduction and oxidation of chloral hydrate by isolated tissues in vitro. J Pharmacol Exp Ther (1949) 0.76
Metabolic demethylation of 3,5-dimethyl-5-ethyl 2,4-oxazolidinedione (paramethadione, paradione). J Pharmacol Exp Ther (1955) 0.75
The metabolic fate of 5-ethyl-1-methyl-5-phenyl hydantoin (1-methylnirvanol) and that of 3,5-diethyl-5-phenyl hydantoin (3-ethylnirvanol). J Pharmacol Exp Ther (1959) 0.75
Quantitative studies of the physiological disposition of 3-methyl-5-ethyl-5-phenyl hydantoin (mesantoin) and 5-ethyl-5-phenyl hydantoin (nirvanol). J Pharmacol Exp Ther (1953) 0.75
SUBSTRATE INDUCTION OF TRYPTOPHAN PYRROLASE IN CHICKEN LIVERS. Guys Hosp Rep (1965) 0.75
A pharmacological comparison of the optical isomers of 5-ethyl-5-phenyl hydantoin (nirvanol) and of 3-methyl-5-ethyl-5-phenyl hydantoin (mesantoin). J Pharmacol Exp Ther (1954) 0.75
A case of temporal arteritis. Med J Aust (1949) 0.75
Metabolic demethylation of 1,3-dimethyl-5-ethyl-5-phenyl hydantoin (dimethylnirvanol). J Pharmacol Exp Ther (1961) 0.75
Bromal hydrate and chloral hydrate; a pharmacological contrast and its chemical basis. J Pharmacol Exp Ther (1948) 0.75
The treatment of epilepsy. Bull Johns Hopkins Hosp (1948) 0.75
Metabolic fate of thiobarbital. Fed Proc (1947) 0.75
Metabolic oxidation of phenobarbital to p-hydroxyphenobarbital. Science (1954) 0.75
Metabolic deëathylation of 5,5-dimethyl-3-ethyl-2,4 oxazolidinedione (dimedion). Arch Int Pharmacodyn Ther (1957) 0.75
SYNTHESIS OF 5,5-DIMETHYL-2,4-OXAZOLIDINEDIONE-2-C14 (DMO-2-C14). J Pharm Sci (1963) 0.75
The metabolic conversion of 3-methyl-5-ethyl-5-phenyl hydantoin (mesantoin) and of 5-ethyl-5-phenyl hydantoin (nirvanol) to 5 - ethyl -5- (p-hydroxyphenyl) hydantoin. J Pharmacol Exp Ther (1956) 0.75
A case of toxic myocarditis due to the common cold with an unusual type of electrocardiogram. Med J Aust (1955) 0.75
Further studies of metabolic removal of alkyl groups from nitrogen in barbituric acid derivatives. Proc Soc Exp Biol Med (1953) 0.75
THE METABOLIC FATE OF CARBROMAL (2-BROMO-2-ETHYLBUTYRYLUREA). J Pharmacol Exp Ther (1964) 0.75
A pharmacological comparison of the optical isomers of 5-ethyl-5-methyl-2,4-oxazolidinedione and of 3,5-dimethyl-5 ethyl-2,4-oxazolidinedione (paramethadione, paradione). J Pharmacol Exp Ther (1955) 0.75